A deletion variant of the Aspergillus fumigatus ribotoxin Asp f 1 induces an attenuated airway inflammatory response in a mouse model of sensitization

Journal of Investigational Allergology and Clinical Immunology

Volumn 20, Issue 1, 2010, Pages 69-75

  Alvarez Garcia E ^a   Batanero, E ^a   Garcia Fernandez R ^a   Villalba, M ^a   Gavilanes, J G ^a   Martinez del Pozo A ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Allergen; Asp f 1; Aspergillus; Ribonuclease; Ribotoxin; Sarcin

Indexed keywords

ALPHA SARCIN; ASP F 1 PROTEIN; ASPERGILLUS FUMIGATUS VACCINE; FUNGUS VACCINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; MYCOTOXIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; ASPERGILLUS FUMIGATUS; CONTROLLED STUDY; DELETION MUTANT; FEMALE; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; LUNG PARENCHYMA; MOUSE; NONHUMAN; NOSE; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFLAMMATION; SENSITIZATION; WILD TYPE;

ALLERGENS; ANIMALS; ASPERGILLUS FUMIGATUS; FEMALE; FUNGAL PROTEINS; GENE DELETION; HYPERSENSITIVITY; IMMUNOGLOBULIN E; LUNG; MICE; MICE, INBRED BALB C; NASAL MUCOSA;

EID: 77249171721     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Greenberger PA. Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol. 2002;10:685-92.
2. Latgè JP. The pathobiology of Aspergillus fumigatus. Trends Microbiol. 2001;9:382-9.
3. Wark PA, Gibson PG. Allergic bronchopulmonary aspergillosis: new concepts of pathogenesis and treatment. Respirology. 2001;6:1-7.
4. Arruda LK, Platts-Mills TA, Fox JW, Chapman MD. Aspergillus fumigatus allergen I, a major IgE-binding protein, is a member of the mitogillin family of cytotoxins. J Exp Med. 1990;172:1529-32.
5. Kao R, Martínez-Ruiz A, Martínez-del-Pozo A, Crameri R, Davies J. Mitogillin and related fungal ribotoxins. Methods Enzymol. 2001;341:324-35.
6. García-Ortega L, Lacadena J, Villalba M, Rodríguez R, Crespo JF, Rodríguez J, Pascual C, Olmo N, Oñaderra M, Martínezdel-Pozo A, Gavilanes JG. Production and characterization of a noncytotoxic deletion variant of the Aspergillus fumigatus allergen Asp f 1 displaying reduced IgE binding. FEBS J. 2005;272:2536-44.
7. Lacadena J, Álvarez-García E, Carreras-Sangrà N, Herrero-Galán E, Alegre-Cebollada J, García-Ortega L, Oñaderra M, Gavilanes JG, Martínez-del-Pozo A. Fungal ribotoxins: molecular dissection of a family of natural killers. FEMS Microbiol Rev. 2007;31:212-37.
8. Yang X, Moffat K. Insights into specificity of cleavage and mechanism of cell entry from the crystal structure of the highly specific Aspergillus ribotoxin, restrictocin. Structure. 1996;4:837-52.
9. Pérez-Cañadillas JM, Santoro J, Campos-Olivas R, Lacadena J, Martínez-del-Pozo A, Gavilanes JG, Rico M, Bruix M. The highly refined solution structure of the cytotoxic ribonuclease α-sarcin reveals the structural requirements for substrate recognition and ribonucleolytic activity. J Mol Biol. 2000;299:1061-73.
10. Olmo N, Turnay J, González de Buitrago G, López de Silanes I, Gavilanes JG, Lizarbe MA. Cytotoxic mechanism of the ribotoxin α-sarcin. Induction of cell death via apoptosis. Eur J Biochem. 2001;268:2113-23.
11. 2-terminal α-hairpin of the ribotoxin α-sarcin produces a nontoxic but active ribonuclease. J Biol Chem. 2002;277:18632-9.
12. García-Mayoral MF, García-Ortega L, Lillo MP, Santoro J, Martínez-del-Pozo A, Gavilanes JG, Rico M, Bruix M. NMR structure of the noncytotoxic α-sarcin mutant Δ(7-22): The importance of the native conformation of peripheral loops for activity. Protein Sci. 2004;13:1000-11.
13. Kurup VP, Kumar A. Immunodiagnosis of aspergillosis. Clin Microbiol Rev. 1991;4:439-56.
14. Crameri R, Hemmann S, Ismail C, Menz G, Blaser K. Disease-specific recombinant allergens for the diagnosis of allergic bronchopulmonary aspergillosis. Int Immunol. 1998;10:1211-6.
15. Kurup VP, Knutsen AP, Moss RB, Bansal NK. Specific antibodies to recombinant allergens of Aspergillus fumigatus in cystic fibrosis patients with ABPA. Clin Mol Allergy 2006;4:11.
16. Valenta R, Niederberger V. Recombinant allergens for immunotherapy. J Allergy Clin Immunol. 2007;119:826-30.
17. Lacadena J, Martínez-del-Pozo A, Barbero JL, Mancheño JM, Gasset M, Oñaderra M, López-Otín C, Ortega S, García J, Gavilanes JG. Overproduction and purification of biologically active native fungal α-sarcin in Escherichia coli. Gene. 1994;142:147-51.
18. Lacadena J, Martínez-del-Pozo A, Martínez-Ruiz A, Pérez-Cañadillas JM, Bruix M, Mancheño JM, Oñaderra M, Gavilanes JG. Role of histidine-50, glutamic acid-96, and histidine-137 in the ribonucleolytic mechanism of the ribotoxin α-sarcin. Proteins. 1999;37:474-84.
19. García-Ortega L, Lacadena J, Lacadena V, Masip M, De Antonio C, Martínez-Ruiz A, Martínez-del-Pozo A. The solubility of the ribotoxin α-sarcin, produced as a recombinant protein in Escherichia coli, is increased in the presence of thioredoxin. Lett Appl Microbiol. 2000;30:298-302.
20. Martínez-Ruiz A, García-Ortega L, Kao R, Lacadena J, Oñaderra M, Mancheño JM, Davies J, Martínez-del-Pozo A, Gavilanes JG. RNase U2 and α-sarcin: A study of relationships. Methods Enzymol. 2001;341:335-51.
21. Batanero E, Barral P, Villalba M, Rodríguez R. Sensitization of mice with olive pollen allergen Ole e 1 induces a Th2 response. Int Arch Allergy Immunol. 2002;127:269-75.
22. Kurup VP, Grunig G. Animal models of allergic bronchopulmonary aspergillosis. Mycopathologia. 2001;153:165-77.
23. Vrtala S. From allergen genes to new forms of allergy diagnosis and treatment. Allergy. 2008;63:299-309.
24. Kurup VP, Kumar A, Kenealy WR, Greenberger PA. Aspergillus ribotoxins react with IgE and IgG antibodies of patients with allergic bronchopulmonary aspergillosis. J Lab Clin Med. 1994;123:749-56.
25. Kurup VP, Xia JQ, Crameri R, Rickaby DA, Choi HY, Flückiger S, Blaser K, Dawson CA, Kelly KJ. Purified recombinant A. fumigatus allergens induce different responses in mice. Clin Immunol. 2001;98:327-36.
26. Svirshchevskaya EV, Viskova N, Shevchenko M, Alekseeva L, Marchenko A, Benevolensky S, Kurup VP. High-affinity IgG to a major A. fumigatus allergen, Asp f 2, retards allergic response. Med Sci Monit. 2004;10:371-80.
27. Hogaboam CM, Blease K, Mehrad B, Steinhauser ML, Standiford TJ, Kunkel SL, Lukacs NW. Chronic airway hyperreactivity, goblet cell hyperplasia, and peribronchial fibrosis during allergic airway disease induced by Aspergillus fumigatus. Am J Pathol. 2000;156:723-32.
28. Kurup VP, Choi H, Resnick A, Kalbfieisch J, Fink JN. Immunopathological response of C57BL/6 and C3H/Hen mice to Aspergillus fumigatus antigens. Int Arch Allergy Appl Immunol. 1990;91:145-54.
29. Kurup VP, Mauze S, Choi HY, Seymour BWP, Coffman RL. A murine model of allergic bronchopulmonary aspergillosis with elevated eosinophils and IgE. J Immunol. 1992;148:3783-8.
30. Reed CE, Kita H. The role of protease activation of inflammation in allergic respiratory diseases. J Allergy Clin Immunol. 2004;114:997-1008.
31. Shen HD, Tam MF, Tang RB, Chou H. Aspergillus and Penicillium allergens: focus on proteases. Curr Allergy Asthma Rep 2007;7:351-6.
32. Tomee JF, Wierenga AT, Hiemstra PS, Kauffman HK. Proteases from Aspergillus fumigatus induce release of proinflammatory cytokines and cell detachment in airway epithelial cell lines. J Infect Dis. 1997;176:300-3.
33. Lamhamedi-Cherradi SE, Martin RE, Ito T, Kheradmand F, Corry DB, Liu YJ, Moyle M. Fungal proteases induce Th2 polarization through limited dendritic cell maturation and reduced production of IL-12. J Immunol. 2008;180:6000-9.